Morris Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Morris Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$64.88 - $75.68 $2.97 Million - $3.46 Million	-45,738 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $28,626 - $34,898	393 Added 0.87%	45,738 $3.45 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $259,057 - $304,096	-3,641 Reduced 7.43%	45,345 $3.25 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $3.53 Million - $4.19 Million	48,986	48,986 $3.97 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Morris Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Morris Capital Advisors, LLC with notifications on news.